Non-COVID-19 ward | COVID-19 ward | ||||||
---|---|---|---|---|---|---|---|
Antibiotic | Number of patients treated | Total no. patients with resistant isolates | No. times used as a monotherapy | Antibiotic | Number of patients treated | Total no. patients with resistant isolates | No. times used as a monotherapy |
Ceftriaxone | 18 (38%) | 1 (2%) | 18 (100%) | Ceftriaxone | 26 (52%) | 0 (0%) | 26 (100%) |
Metronidazole | 6 (13%) | Not reported | 6 (100%) | Cloxacillin | 3 (6%) | 1 (2%) | 3 (100%) |
Cloxacillin | 5 (10%) | 0 (0%) | 5 (100%) | Gentamicin | 2 (4%) | 11 (22%) | 2 (100%) |
Gentamicin | 4 (8%) | 7 (15%) | 4 (100%) | Cotrimoxazole | 2 (4%) | 7 (14%) | 2 (100%) |
Cotrimoxazole | 2 (4%) | 4 (8%) | 2 (100%) | Levofloxacin | 2 (4%) | 0 (0%) | 2 (100%) |